SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,717,146 | +2.2% | 22,415 | -3.4% | 0.02% | +7.1% |
| Q2 2023 | $2,658,353 | -28.9% | 23,213 | -14.4% | 0.01% | -33.3% |
| Q1 2023 | $3,736,709 | +3.2% | 27,111 | -5.4% | 0.02% | -43.2% |
| Q4 2022 | $3,622,522 | +57.8% | 28,666 | +38.0% | 0.04% | +37.0% |
| Q3 2022 | $2,296,000 | +55.8% | 20,767 | +8.6% | 0.03% | +68.8% |
| Q2 2022 | $1,474,000 | -2.6% | 19,129 | -1.3% | 0.02% | +23.1% |
| Q1 2022 | $1,514,000 | -18.1% | 19,379 | -5.6% | 0.01% | -13.3% |
| Q4 2021 | $1,849,000 | +15.1% | 20,535 | +18.2% | 0.02% | +7.1% |
| Q3 2021 | $1,606,000 | +26.7% | 17,370 | +6.5% | 0.01% | +27.3% |
| Q2 2021 | $1,268,000 | +38.3% | 16,306 | +32.6% | 0.01% | +57.1% |
| Q1 2021 | $917,000 | -61.4% | 12,299 | -50.7% | 0.01% | -12.5% |
| Q4 2020 | $2,374,000 | – | 24,926 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |